XML 32 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Convertible Series E Preferred Stock
Non-IPO
IPO
Charitable Contribution, IPO
Total Unity Stockholders' Equity
Total Unity Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Total Unity Stockholders' Equity
Convertible Series E Preferred Stock
Total Unity Stockholders' Equity
Non-IPO
Total Unity Stockholders' Equity
IPO
Total Unity Stockholders' Equity
Charitable Contribution, IPO
Convertible Preferred Stock
Convertible Preferred Stock
Convertible Series E Preferred Stock
Common Stock
Common Stock
Non-IPO
Common Stock
IPO
Common Stock
Charitable Contribution, IPO
Additional Paid-In Capital
Additional Paid-In Capital
Non-IPO
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Charitable Contribution, IPO
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
 [1]
Beginning balance (in shares) at Dec. 31, 2019                         95,899,214                          
Beginning balance at Dec. 31, 2019 $ 393,911           $ 393,911           $ 686,559   $ 1       $ 226,173       $ (3,632) $ (515,190)   $ 0
Beginning balance (in shares) at Dec. 31, 2019                             123,261,024                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Issuance of stock (in shares)                           6,818,182   4,545,455 28,750,000 750,000                
Issuance of stock     $ 149,970 $ 100,000 $ 1,417,582 $ 63,615     $ 149,970 $ 100,000 $ 1,417,582 $ 63,615   $ 149,970           $ 100,000 $ 1,417,582 $ 63,615        
Issuance of common stock from employee equity plans (in shares)                             12,415,153                      
Issuance of common stock from employee equity plans 34,260           34,260                       34,260              
Common stock issued in connection with acquisitions (in shares)                             1,103,190                      
Common stock issued in connection with acquisitions 25,380           25,380                       25,380              
Purchase and retirement of stock (in shares)                             (5,000)                      
Purchase and retirement of common stock (110)           (110)                       (110)              
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)                         (102,717,396)   102,717,396                      
Conversion of convertible preferred stock to common stock upon initial public offering             0           $ (836,529)   $ 1       836,528              
Stock‑based compensation expense 134,629           134,629                       134,629              
Net loss (282,308)           (282,308)                                 (282,308)    
Other comprehensive income (loss) 214           214                               214      
Ending balance (in shares) at Dec. 31, 2020                         0                          
Ending balance at Dec. 31, 2020 $ 2,037,143 $ (1,522)         2,037,143 $ (1,522)         $ 0   $ 2       2,838,057       (3,418) (797,498) $ (1,522) 0
Ending balance (in shares) at Dec. 31, 2020                             273,537,218                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Issuance of common stock from employee equity plans (in shares) 11,650,963                           11,650,963                      
Issuance of common stock from employee equity plans $ 66,704           66,704                       66,704              
Issuance of common stock for settlement of RSUs (in shares)                             3,935,813                      
Common stock issued in connection with acquisitions (in shares)                             3,468,362                      
Common stock issued in connection with acquisitions 526,081           526,081                       526,081              
Purchase of capped calls (48,127)           (48,127)                       (48,127)              
Stock‑based compensation expense 347,159           347,159                       347,159              
Net loss (532,607)           (532,607)                                 (532,607)    
Other comprehensive income (loss) (440)           (440)                               (440)      
Ending balance (in shares) at Dec. 31, 2021                         0                          
Ending balance at Dec. 31, 2021 $ 2,394,391           2,394,391           $ 0   $ 2       3,729,874       (3,858) (1,331,627)   0
Ending balance (in shares) at Dec. 31, 2021 292,592,000                           292,592,356                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Issuance of common stock from employee equity plans (in shares) 4,512,850                           5,119,859                      
Issuance of common stock from employee equity plans $ 63,493           63,493                       63,493              
Issuance of common stock for settlement of RSUs (in shares)                             6,545,464                      
Common stock issued in connection with acquisitions (in shares)                             112,716,696                      
Common stock issued in connection with acquisitions 2,932,228           2,932,228                       2,932,228              
Purchase and retirement of stock (in shares)                             (42,731,179)                      
Purchase and retirement of common stock (1,500,000)           (1,500,000)                       (1,500,000)              
Stock‑based compensation expense 549,671           549,671                       549,671              
Capital contribution from minority interest holder 13,767           7,380                       7,380             6,387
Net loss (919,488)                                                  
Net loss, including adjustment to redeemable noncontrolling interests (921,151)           (921,062)                       (2,870)         (918,192)   (89)
Other comprehensive income (loss) 2,167           2,167                               2,167      
Ending balance (in shares) at Dec. 31, 2022                         0                          
Ending balance at Dec. 31, 2022 $ 3,534,566           $ 3,528,268           $ 0   $ 2       $ 5,779,776       $ (1,691) $ (2,249,819)   $ 6,298
Ending balance (in shares) at Dec. 31, 2022 374,243,000                           374,243,196                      
[1] Excludes redeemable noncontrolling interests.